CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,999 enrolled
Drug / intervention
InSync Model 8040 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00273182
NCT00273182N/ACompleted

InSync Model 8040 (InSync) and InSync III Model 8042 (InSync III) Systems for Cardiac Resynchronization Therapy (CRT) - InSync Registry

Medtronic Cardiac Rhythm and Heart Failure·observational·Posted Jan 9, 2006·Updated Aug 5, 2013

In Brief

An observational study evaluating InSync Model 8040 and InSync III Model 8042 for Heart Failure and Cardiomyopathy. Completed, enrolled 1,999 participants across 82 sites.

Detailed Summary

Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. When there are changes in the heart beat sometimes an implantable heart device is used to control the rate and rhythm of the heart beat. In certain heart failure cases, when the two lower chambers of the heart no longer beat in a coordinated manner, cardiac resynchronization therapy (CRT) may be prescribed. CRT is similar to a pacemaker. It is placed (implanted) under the skin of the upper chest. CRT is delivered as tiny electrical pulses to the right and left ventricles through three or four leads (soft insulated wires) that are inserted through the veins to the heart. The purpose of this study is to monitor the long-term performance of the InSync Model 8040 (InSync) and InSync III Model 8042 (InSync III) systems for cardiac resynchronization therapy (CRT).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 9, 2006
Enrollment StartMar 1, 2002
Primary CompletionApr 1, 2011
TodayJul 2, 2026
Enrollment to primary: 9.1 yearsPosted 20.5 years ago

Interventions

InSync Model 8040device

Subjects with sucessful implants of InSync Model 8040.

InSync III Model 8042device

Subjects with successful implants of InSync III Model 8042